TrialCancer2015

Results of phase 2 randomized study of low-dose decitabine with or without valproic acid in patients with myelodysplastic syndrome and acute myelogenous leukemia.

Jean-Pierre Issa et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.